Therapeutic Targeting of Hepatic Macrophages for the Treatment of Liver Diseases
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: 10.3389/fimmu.2019.02852
- Ereignis
-
Veröffentlichung
- (wo)
-
Aachen
- (wer)
-
Universitätsbibliothek der RWTH Aachen
- (wann)
-
2019
- Urheber
- DOI
-
10.18154/RWTH-2020-00725
- URN
-
urn:nbn:de:101:1-2020111307164936773388
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:33 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- van der Heide, Daphne
- Weiskirchen, Ralf
- Bansal, Ruchi
- Universitätsbibliothek der RWTH Aachen
Entstanden
- 2019
Ähnliche Objekte (12)
Identification and functional analysis of the LIM domain protein CRP2, a marker of hepatic stellate cells
Targeting copper to combat macrophage-driven inflammation: a potential advanced therapeutic strategy
Targeting copper to combat macrophage-driven inflammation: a potential advanced therapeutic strategy
Established Hepatic Stellate Cell Lines in Hepatology Research
Differentielle Genaktivität in v-myc-transformierten Wachtelfibroblasten
Special Issue on "Cellular and Molecular Mechanisms Underlying the Pathogenesis of Hepatic Fibrosis"
Special Issue on "Cellular and Molecular Mechanisms Underlying the Pathogenesis of Hepatic Fibrosis II"
Physalin B attenuates liver fibrosis via suppressing LAP2 alpha-HDAC1 mediated deacetylation of glioma-associated oncogene 1 and hepatic stellate cell activation
Insights in Gastrointestinal and hepatic pharmacology: 2021
Role of SCAP/SREBP in Hepatic Steatosis
Editorial: Insights in Gastrointestinal and Hepatic Pharmacology: 2021
The Role of SCAP/SREBP as Central Regulators of Lipid Metabolism in Hepatic Steatosis
Identification and functional analysis of the LIM domain protein CRP2, a marker of hepatic stellate cells
Targeting copper to combat macrophage-driven inflammation: a potential advanced therapeutic strategy
Targeting copper to combat macrophage-driven inflammation: a potential advanced therapeutic strategy
Established Hepatic Stellate Cell Lines in Hepatology Research
Differentielle Genaktivität in v-myc-transformierten Wachtelfibroblasten
Special Issue on "Cellular and Molecular Mechanisms Underlying the Pathogenesis of Hepatic Fibrosis"
Special Issue on "Cellular and Molecular Mechanisms Underlying the Pathogenesis of Hepatic Fibrosis II"
Physalin B attenuates liver fibrosis via suppressing LAP2 alpha-HDAC1 mediated deacetylation of glioma-associated oncogene 1 and hepatic stellate cell activation
Insights in Gastrointestinal and hepatic pharmacology: 2021
Role of SCAP/SREBP in Hepatic Steatosis
Editorial: Insights in Gastrointestinal and Hepatic Pharmacology: 2021
The Role of SCAP/SREBP as Central Regulators of Lipid Metabolism in Hepatic Steatosis
Identification and functional analysis of the LIM domain protein CRP2, a marker of hepatic stellate cells
Targeting copper to combat macrophage-driven inflammation: a potential advanced therapeutic strategy
Targeting copper to combat macrophage-driven inflammation: a potential advanced therapeutic strategy
Established Hepatic Stellate Cell Lines in Hepatology Research
Differentielle Genaktivität in v-myc-transformierten Wachtelfibroblasten
Special Issue on "Cellular and Molecular Mechanisms Underlying the Pathogenesis of Hepatic Fibrosis"
Special Issue on "Cellular and Molecular Mechanisms Underlying the Pathogenesis of Hepatic Fibrosis II"
Physalin B attenuates liver fibrosis via suppressing LAP2 alpha-HDAC1 mediated deacetylation of glioma-associated oncogene 1 and hepatic stellate cell activation
Insights in Gastrointestinal and hepatic pharmacology: 2021
Role of SCAP/SREBP in Hepatic Steatosis
Editorial: Insights in Gastrointestinal and Hepatic Pharmacology: 2021